Two Sigma Investments, LP Repligen Corp Transaction History
Two Sigma Investments, LP
- $41.6 Billion
- Q4 2024
A detailed history of Two Sigma Investments, LP transactions in Repligen Corp stock. As of the latest transaction made, Two Sigma Investments, LP holds 359,039 shares of RGEN stock, worth $56.2 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
359,039
Previous 436,163
17.68%
Holding current value
$56.2 Million
Previous $64.9 Million
20.38%
% of portfolio
0.12%
Previous 0.15%
Shares
17 transactions
Others Institutions Holding RGEN
# of Institutions
482Shares Held
56.3MCall Options Held
251KPut Options Held
458K-
Black Rock Inc. New York, NY7.57MShares$1.18 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.14MShares$1.12 Billion0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$799 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$265 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.54MShares$242 Million1.48% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.69B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....